Skip to content

Clinical trials

Completed Phase 2/3 trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Completed Country / region: Serbia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20082
20101
20111
20121
20151
20163
20171
20183
20192
20201
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
argenx2
ACADIA Pharmaceuticals Inc.1
BioCryst Pharmaceuticals1
Celgene1
Celyad Oncology SA1
Center for Health Sciences, Serbia1
Clinic for Psychiatric Disorders, Dr Laza Lazarevic1
Dermatology Specialties Limited Partnership1
EMD Serono1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative3
Angioedemas, Hereditary1
Demyelinating Diseases1
Depressive Disorder1
Dermatomyositis1
Diabetes Mellitus, Type 21
Disease1
Hearing Loss, Sudden1
Heart Failure1
Hypertension, Pulmonary1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.